https://www.selleckchem.com/pr....oducts/Staurosporine
81) or 30-day mortality (p = 0.61). Patients cared for by the GSV Program had a reduced postoperative length of stay (median 4 days [range 1,31] vs. 5 days [range 1,86]; p 0.01; and mean 5.4 ± 4.8 vs. 8.8 ± 11.8 days; p 0.01) compared with the matched cohort. In a multivariable regression model, the GSV Program's reduced length of stay was independent of other associated covariates including age, operative time, and comorbidities (p 0.01). Preliminary implementation of the GSV Program standards reduces length of sta
Like
Comment
Share
